{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:15:39Z","timestamp":1793643339260,"version":"4.5.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH113477"],"award-info":[{"award-number":["MH113477"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001442"],"award-info":[{"award-number":["UL1TR001442"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The Aspergillus Galactomannan Lateral Flow Assay (LFA) is a rapid test for the diagnosis of invasive aspergillosis (IA) that has been almost exclusively evaluated in patients with hematologic malignancies. An automated digital cube reader that allows for quantification of results has recently been added to the test kits.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a retrospective multicenter study on bronchoalveolar lavage fluid (BALF) samples obtained from 296 patients with various underlying diseases (65% without underlying hematological malignancy) who had BALF galactomannan (GM) ordered between 2013 and 2019 at the University of California, San Diego, the Medical University of Graz, Austria, and the Mannheim University Hospital, Germany.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Cases were classified as proven (n = 2), probable (n = 56), putative (n = 30), possible (n = 45), and no IA (n = 162). The LFA showed an area under the curve (AUC) of 0.865 (95% confidence interval [CI] .815\u2013.916) for differentiating proven\/probable or putative IA versus no IA, with a sensitivity of 74% and a specificity of 83% at an optical density index cutoff of 1.5. After exclusion of GM as mycological criterion for case classification, diagnostic performance of the LFA was highly similar to GM testing (AUC 0.892 vs 0.893, respectively). LFA performance was consistent across different patient cohorts and centers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this multicenter study the LFA assay from BALF demonstrated good diagnostic performance for IA that was consistent across patient cohorts and locations. The LFA may serve a role as a rapid test that may replace conventional GM testing in settings where GM results are not rapidly available.<\/jats:p><\/jats:sec>","DOI":"10.1093\/cid\/ciaa1281","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T19:13:35Z","timestamp":1598469215000},"page":"e1737-e1744","source":"Crossref","is-referenced-by-count":73,"title":["Performance of the Bronchoalveolar Lavage Fluid<i>Aspergillus<\/i>Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study"],"prefix":"10.1093","volume":"73","author":[{"given":"Jeffrey D","family":"Jenks","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, University of California San Diego, San Diego, California, USA"},{"name":"Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA"},{"name":"Clinical and Translational Fungal-Working Group, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Prattes","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine and Division of Pulmonology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Frank","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine and Division of Pulmonology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Spiess","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mannheim University Hospital, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay R","family":"Mehta","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA"},{"name":"Clinical and Translational Fungal-Working Group, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Boch","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mannheim University Hospital, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Buchheidt","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Mannheim University Hospital, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA"},{"name":"Clinical and Translational Fungal-Working Group, University of California San Diego, La Jolla, California, USA"},{"name":"Section of Infectious Diseases and Tropical Medicine and Division of Pulmonology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"2021100522224754900_CIT0001","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"2021100522224754900_CIT0002","first-page":"459405","article-title":"Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome","volume":"2013","author":"Barton","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"2021100522224754900_CIT0003","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2021100522224754900_CIT0004","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","article-title":"Diagnosing COVID-19-associated pulmonary aspergillosis","volume":"1","author":"Verweij","year":"2020","journal-title":"Lancet Microbe"},{"key":"2021100522224754900_CIT0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated Pulmonary Aspergillosis (CAPA): from immunology to treatment","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2021100522224754900_CIT0006","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa242","article-title":"Invasive aspergillosis as an underrecognized superinfection in COVID-19","author":"Thompson","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2021100522224754900_CIT0007","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1080\/13693780902718339","article-title":"Risk stratification for invasive aspergillosis: early assessment of host susceptibility","volume":"47","author":"Patterson","year":"2009","journal-title":"Med Mycol"},{"key":"2021100522224754900_CIT0008","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/myc.12628","article-title":"Improving outcome of fungal diseases: guiding experts and patients towards excellence","volume":"60","author":"Cornely","year":"2017","journal-title":"Mycoses"},{"key":"2021100522224754900_CIT0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/myc.12343","article-title":"Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients","volume":"58","author":"Prattes","year":"2015","journal-title":"Mycoses"},{"key":"2021100522224754900_CIT0010","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13148","article-title":"Breakthrough invasive fungal infections: who is at risk?","author":"Jenks","year":"2020","journal-title":"Mycoses"},{"key":"2021100522224754900_CIT0011","first-page":"528","article-title":"Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis","volume":"55","author":"Eigl","year":"2017","journal-title":"Med Mycol"},{"key":"2021100522224754900_CIT0012","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jinf.2018.05.001","article-title":"Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples","volume":"77","author":"Heldt","year":"2018","journal-title":"J Infect"},{"key":"2021100522224754900_CIT0013","first-page":"CD007394-CD","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2015","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2021100522224754900_CIT0014","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.00345-17","article-title":"Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis","volume":"55","author":"Zhou","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2021100522224754900_CIT0015","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/mmy\/myx066","article-title":"Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia Fungal Working Group (AFWG) initiative","volume":"56","author":"Chindamporn","year":"2018","journal-title":"Med Mycol"},{"key":"2021100522224754900_CIT0016","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/JCM.00467-14","article-title":"Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis","volume":"52","author":"Hoenigl","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2021100522224754900_CIT0017","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/QCO.0000000000000408","article-title":"The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients: strengths and weaknesses","volume":"30","author":"Buchheidt","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"2021100522224754900_CIT0018","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/JCM.01767-09","article-title":"Aspergillus PCR: one step closer to standardization","volume":"48","author":"White","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2021100522224754900_CIT0019","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing","volume":"61","author":"White","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021100522224754900_CIT0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmi.2015.09.009","article-title":"Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis","volume":"22","author":"Springer","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2021100522224754900_CIT0021","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection: position paper of the Mycoses Study Group Education and Research Consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"2021100522224754900_CIT0022","first-page":"E18","article-title":"Blood Aspergillus PCR: the good, the bad, and the ugly","volume":"6","author":"Egger","year":"2020","journal-title":"J Fungi (Basel, Switzerland)"},{"key":"2021100522224754900_CIT0023","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/JCM.01365-14","article-title":"PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance","volume":"52","author":"Arvanitis","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2021100522224754900_CIT0024","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/myc.12881","article-title":"Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage","volume":"62","author":"Jenks","year":"2019","journal-title":"Mycoses"},{"key":"2021100522224754900_CIT0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jinf.2018.10.014","article-title":"Bronchoalveolar lavage Aspergillus Galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies","volume":"78","author":"Jenks","year":"2019","journal-title":"J Infect"},{"key":"2021100522224754900_CIT0026","first-page":"myz079","article-title":"Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: a comparative multicenter study","author":"Mercier","year":"2019","journal-title":"Med Mycol"},{"key":"2021100522224754900_CIT0027","doi-asserted-by":"crossref","first-page":"1563.e1","DOI":"10.1016\/j.cmi.2019.08.009","article-title":"Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMY\u2122): real-life data from a multicentre study","volume":"25","author":"Lass-Fl\u00f6rl","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2021100522224754900_CIT0028","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","author":"Donnelly","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021100522224754900_CIT0029","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2021100522224754900_CIT0030","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s00108-017-0334-9","article-title":"Aspergillus in airway material: Ignore or treat?","volume":"58","author":"Salzer","year":"2017","journal-title":"Internist (Berl)"},{"key":"2021100522224754900_CIT0031","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2021100522224754900_CIT0032","article-title":"Prospective evaluation of the turbidimetric \u03b2-D-glucan assay and two lateral flow assays on serum in invasive aspergillosis","author":"Mercier","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021100522224754900_CIT0033","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JCM.06423-11","article-title":"Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity","volume":"50","author":"D\u2019Haese","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2021100522224754900_CIT0034","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1086\/647935","article-title":"Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases","volume":"49","author":"Maertens","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021100522224754900_CIT0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jinf.2017.11.011","article-title":"Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in bronchoalveolar lavage fluid: comparison of non-culture-based assays","volume":"76","author":"Guegan","year":"2018","journal-title":"J Infect"},{"key":"2021100522224754900_CIT0036","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jinf.2016.02.019","article-title":"Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients","volume":"72","author":"Fort\u00fan","year":"2016","journal-title":"J Infect"},{"key":"2021100522224754900_CIT0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.065","article-title":"Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill adult patients: a systematic review with qualitative evidence synthesis","author":"Bassetti","year":"2020","journal-title":"J Infect"},{"key":"2021100522224754900_CIT0038","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijantimicag.2015.05.017","article-title":"Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test","volume":"46","author":"Eigl","year":"2015","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1281\/34030637\/ciaa1281.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/e1737\/40510996\/ciaa1281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/e1737\/40510996\/ciaa1281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T09:56:12Z","timestamp":1696586172000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/7\/e1737\/5899800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,8,31]]},"published-print":{"date-parts":[[2021,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1281","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2020,8,31]]}}}